Istituto Nazionale di Ricovero e Cura per Anziani Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01709058
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Istituto di Ricovero e Cura per Anziani | Istituto Nazionale di Ricovero e Cura per Anziani

Active Ingredients

Drugs in Phase 4 Trials (1)

ozone (1 trial)

Drugs in Other Trials (2)

fiber (1 trial)

prebiotic fiber (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3